Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may be linked to contrast-associated acute kidney injury (CA-AKI) in adults with type 2 diabetes and chronic kidney disease.
- Contrast-enhanced computed tomography (CE-CT) and computed tomographic angiography (CTA) are common imaging techniques that can pose risks for kidney injury.
- Adults with type 2 diabetes and chronic kidney disease may have an elevated risk of acute kidney injury after receiving contrast agents.
- GLP-1 RA use is being evaluated for its potential relationship with CA-AKI in this patient population.
- Understanding this association could inform clinical decisions regarding the use of GLP-1 RAs in patients undergoing imaging procedures.
Simplified